Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 15, 1985 - Issue 11
Submit an article Journal homepage
19
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The pharmocokinetics of bucindolol and its major metabolite in essential hypertension

P. A. Meredith University of Glasgow, Department of Materia Medica, Stobhill General Hospital, Glasgow, G21 3UW, UK
,
A. W. Kelman Department of Clinical Physics and Bioengineering, University of Glasgow, 11 West Graham Street, Glasgow, UK
,
D. R. McSharry University of Glasgow, Department of Materia Medica, Stobhill General Hospital, Glasgow, G21 3UW, UK
,
J. Vincent University of Glasgow, Department of Materia Medica, Stobhill General Hospital, Glasgow, G21 3UW, UK
&
J. L. Reid University of Glasgow, Department of Materia Medica, Stobhill General Hospital, Glasgow, G21 3UW, UK
Pages 979-985 | Received 24 Jan 1985, Published online: 30 Sep 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eric Black-Maier, Benjamin A Steinberg & Jonathan P Piccini. (2015) Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure. Expert Review of Cardiovascular Therapy 13:6, pages 627-636.
Read now

Articles from other publishers (4)

Jaekyu Shin & Julie A. Johnson. (2008) β-Blocker pharmacogenetics in heart failure. Heart Failure Reviews 15:3, pages 187-196.
Crossref
Eric J. Eichhorn. (1993) Effects of bucindolol in heart failure. The American Journal of Cardiology 71:9, pages C65-C70.
Crossref
PC O'Connor, MJ Finch, DW Harron, PA Meredith, DG McDevitt & RG Shanks. (2012) Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.. British Journal of Clinical Pharmacology 20:6, pages 659-667.
Crossref
J. Webster, JC Petrie, OJ Robb, M. Jamieson & J. Verschueren. (2012) A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.. British Journal of Clinical Pharmacology 20:4, pages 393-400.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.